China reiterates commitment to tackle antitrust issues in pharma sector
China will strengthen enforcement against anticompetitive conduct in the pharmaceutical sector, according to a statement issued by the country’s Ministry of Industry and Information Technology.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.